30 Day Trial

Alphatec Spine Reports 4Q15/2015 Revenue

Share:

Alphatec Spine posted 4Q15 revenue of US $47.0MM, -9.4% vs. 4Q14, and 2015 revenue of $185.3MM, -5.2% vs. 2014. (2015: U.S. $114.6MM, -16.4%; ex-U.S. $70.7MM, +16.9%) Growth reflects constant currency.

Source: Alphatec Spine, Inc.

ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows.

  • Spine $168.5MM, -10.6%
  • Orthobiologics $16.8MM, -10.1%

 

Company leadership noted progress in its strategic initiatives, including the completion of: 

  • All manufacturing now 100% outsourced
  • Pilot phase partnership with UPS on outsourcing implant/instrument set distribution (expects 100% completion in 3Q16)
  • Expansion into new international geographies, including a new distribution partner in Australia in 1Q16